Main Article Content


Heart failure may cause liver damage, known as cardiomyopathy cirrhosis. Conversely, liver disease could also lead to heart failure and cardiovascular abnormalities. Cirrhotic cardiomyopathy is a relatively rare disease. Diagnosis should be found out as early as possible to prevent complications. Unfortunately, epidemiology data of cirrhotic cardiomyopathy is still limited, and the prevalence is still not precisely known. Hence, we reported a case of a young man with the main problem of right-sided heart failure and suspected cardiac cirrhosis with unclear manifestation. This case has a good outcome so that we hope this report could give a great reference on treating cardiomyopathy cirrhosis.


Cardiomyopathy cirrhosis Male Heart failure Pulmonary hypertension

Article Details

How to Cite
Nugraha, I. B. A. (2021). Diagnostic problems of right-sided heart failure patient with cardiomyopathy cirrhosis. Neurologico Spinale Medico Chirurgico, 4(2), 58-62.


  1. Fouad YM, Yehia R. Hepato-cardiac disorders. World Journal of Hepatology. 2014;6(1):41–54. DOI:10.4254/wjh.v6.i1.41
  2. Myers RP, Cerini R, Sayegh R. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37(1):393-400. DOI: 10.1053/jhep.2003.50062
  3. Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol. 2007;139(13):1912-1927. DOI: 10.3748/wjg.v13.i13.1912
  4. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. European Journal of Heart Failure.2009;11(1):170-177. DOI: 10.1093/eurjhf/hfn031
  5. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure (Abstract). Clin Liver Dis 6. 2002;(4):947–67. DOI: 10.1016/s1089-3261(02)00056-9
  6. Pudil R, Pelouch R, Praus R, et al. Heart failure in patients with liver cirrhosis. Cor et Vasa. 2013; 55(4):391–96. DOI: 10.1016/j.crvasa.2013.06.002
  7. Fede G, Privitera G, Tomaselli T, et al. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015;28(1):31– 40
  8. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut. 2001;49(2):268-275. DOI:10.1136/gut.49.2.268
  9. Pateron D, Beyne P, Laperche T, et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology. 1999;29(3):640-643. DOI:10.1002/hep.510290332
  10. Ceolotto G, Papparella I, Sticca A, et al. An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. Hepatology. 2008;48(6):1913-1923. DOI:10.1002/hep.22533
  11. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet Journal of Rare Diseases. 2007; 15(2):1-8. DOI:10.1186/1750- 1172-2-15
  12. Gaskari SA, Liu H, Moezi L, et al. role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146(3):315-323. DOI:10.1038/sj.bjp.0706331
  13. Wong F, Liu P, Allidina Y, et al. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis. Gastroenterology. 1995;108(6):1820-1827. DOI:10.1016/0016-5085(95)90145-0
  14. Shepherd AN, Hayes PC, Jacyna M, et al. The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol. 1985;19(3):393-397. DOI:10.1111/j.1365-2125.1985.tb02659.x
  15. Gentilini P, Romanelli RG, La Villa G, et al. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology. 1993;104(2):588-594. DOI: 10.1016/0016-5085(93)90431-b